GLP-1 Receptor Agonist Market to reach USD 55.8 billion by 2032, Says Graphical Research Powered by GMI
June 13, 2023 17:30 ET
|
Graphical Research
Selbyville, Delaware, June 13, 2023 (GLOBE NEWSWIRE) -- GLP-1 Receptor Agonist Market size is estimated to amass USD 55.8 billion by 2032. The industry is set to observe notable growth driven...
Gestational Diabetes Treatment Market In Asia Pacific Is Relied Upon To Observe Quicker Development Forecast Till 2030 Analysis Covid-19 Impact: Acumen Research And Consulting
June 16, 2021 12:16 ET
|
Acumen Research and Consulting
LOS ANGELES, June 16, 2021 (GLOBE NEWSWIRE) -- Gestational diabetes is a type of diabetes that can develop during pregnancy in women who don’t already have diabetes. Gestational diabetes occurs when...
Sirona Biochem Releases Quarterly Financial Results
June 29, 2012 09:00 ET
|
Sirona Biochem Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 29, 2012) - Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB) announced today it has released its quarterly financial...
VIDEO From GI Dynamics and Synaptic Digital: Select U.K. Centres Offer New Treatment for Type 2 Diabetes
June 11, 2012 03:00 ET
|
Synaptic Digital a Definition 6 Company
LEXINGTON, Mass. and BERKSHIRE, England, June 11, 2012 (GLOBE NEWSWIRE) -- Diabetes affects 3.7 million people in the United Kingdom (U.K.) and another 7 million people are currently at risk for...
Washington, DC Weight Loss Surgeons Discuss New Link Between Obesity Surgery and Diabetes Treatment
May 16, 2012 05:09 ET
|
Bluepoint Surgical Group
WASHINGTON, DC--(Marketwire - May 16, 2012) - Thanks to two recent studies published in The New England Journal of Medicine, researchers and surgeons have established a tangible link between...
Sirona Biochem Announces Diabetes Preclinical Results in Chronic Study
February 29, 2012 09:00 ET
|
Sirona Biochem Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 29, 2012) - Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB), announced today its lead compound for the treatment of Type 2...